Related Experiment Videos
Central serotonergic mechanisms in hypertension
J P Chalmers1, P M Pilowsky, J B Minson
1Department of Medicine, Flinders Medical Centre, Bedford Bank, South Australia.
American Journal of Hypertension
|January 1, 1988
Summary
Different serotonin neuron groups control blood pressure. Some increase arterial pressure via midbrain projections, while others, like midline B3 cells, lower it. Methyldopa
Area of Science:
- Neuroscience
- Cardiovascular Physiology
Background:
- Serotonin neurons in the central nervous system have diverse projections.
- These neurons are implicated in regulating various physiological functions, including blood pressure.
Purpose of the Study:
- To investigate the distinct roles of different serotonin neuron groups in regulating arterial pressure.
- To elucidate the mechanisms by which specific serotonin pathways influence blood pressure.
- To determine the involvement of central serotonin pathways in the hypotensive effect of methyldopa.
Main Methods:
- Electrophysiological recordings in vivo.
- Pharmacological manipulations.
- Neuronal pathway tracing techniques.
Main Results:
- Activation of midbrain serotonin projections to the hypothalamus elevates arterial pressure.
- Activation of spinal cord descending projections from lateral B3 serotonin cells causes a pressor response, independent of C1 adrenaline neurons.
- Activation of midline B3 serotonin cells in the raphe nucleus induces a hypotensive response.
- The hypotensive effect of methyldopa is partially mediated by central serotonin pathways.
Conclusions:
- Different serotonin neuron populations exert opposing effects on arterial pressure.
- Specific serotonin pathways in the brainstem and spinal cord differentially regulate cardiovascular function.
- Central serotonin systems are key mediators of methyldopa's blood pressure-lowering effects.